Strategically located amidst the serene landscapes of Sikkim, Indchemie's state-of-the-art manufacturing facility spans an impressive 1,819 sq. meters of area, with a built-up space of 3,930 sq. meters, making it one of the most advanced pharmaceutical plants in the region.

Designed to meet international standards, the facility boasts high-volume production capabilities with an annual capacity of 250 million tablets, 100 million Capsules, 5 million Ointment & 15 million litres of liquid formulations. This robust infrastructure supports a wide spectrum of therapeutic segments, ensuring consistent quality and scalability to meet growing global demand. It also produces 75 million Betalactam Tablets and 6 million Dry Syrup.

Equipped with cutting-edge machinery, automated systems, and stringent quality control protocols, the Sikkim plant reflects Indchemie's unwavering commitment to innovation, regulatory compliance, and excellence in healthcare manufacturing.